Davis Polk advised the joint book-running managers in the offering. Beam Therapeutics Inc. completed its offering of 5,750,000 common shares for total gross proceeds of $127…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
